IX Interdyscyplinarna Konferencja Amyloidoza
2025-10-03 - 2025-10-04
Zapraszamy na IX Interdyscyplinarną Konferencję Amyloidoza, która odbędzie się w dniach 3-4 października 2025 r. w formule on-line.
Celem Konferencji jest aktualizacja wiedzy na temat amyloidozy oraz wymiana doświadczeń pomiędzy lekarzami różnych specjalności medycznych. Mamy nadzieję, że Konferencja przyczyni się do poprawy diagnostyki i terapii amyloidozy w Polsce, a także stanie się impulsem do wspólnych inicjatyw klinicznych i naukowych.
Szczegółowe informacje oraz możliwość rejestracji dostępne są na stronie wydarzenia.

Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management
2026-03-13 08:00 - 2026-03-15 17:00 (Europe/Warsaw)
Join us March 13-15, 2026, for the virtual Masterclass in Cardiac Amyloidosis: Disease Spectrum, Diagnosis and Management.
Led by Program Chair, Saurabh Malhotra, MD, MPH, FASNC, Masterclass features multidisciplinary content that today’s practitioners need to keep current in the rapidly advancing field of cardiac amyloidosis.
Masterclass will cover:

the pathogenesis of cardiac amyloidosis;
diagnostic techniques and pitfalls;
management strategies;
mechanisms to facilitate early diagnosis; and
treatment and management.

The program will feature in-depth sessions led by expert cardiologists, multimodality imagers, hematologists, and neurologists to discuss the disease spectrum, diagnosis, and management of cardiac amyloidosis.
For Technologists: There will be a two-hour session, “Amyloidosis for Technologists: Tips and Tricks from Experts“.
This session is essential for technologists who are or will be performing radionuclide imaging for cardiac amyloidosis. Leading experts will guide you through an overview of the disease, image acquisition and processing and recommendations to avoid potential pitfalls.
This program is offered free of charge.
Register Now

ICA 2026: 20. International Conference on Amyloidosis
2026-05-25 08:00 - 2026-05-26 17:00
The International Research Conference Aims and Objectives

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations. With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Amyloidosis aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Amyloidosis. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Amyloidosis.

Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters. Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or theoretical work in all areas of Amyloidosis are cordially invited for presentation at the conference. The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference’s strict guidelines for accepting scholarly papers. Downloadable versions of the check list for Full-Text Papers and Abstract Papers.
Please refer to the Paper Submission Guideline, Abstract Submission Guideline and Author Information before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers. The peer-reviewed conference proceedings are indexed in the Open Science Index, Google Scholar, Semantic Scholar, Zenedo, BASE, WorldCAT, Sherpa/RoMEO, and other index databases. Impact Factor Indicators.
Special Journal Issues
20. International Conference on Amyloidosis has teamed up with the Special Journal Issue on Amyloidosis. A number of selected high-impact full text papers will also be considered for the special journal issues. All submitted papers will have the opportunity to be considered for this Special Journal Issue. The paper selection will be carried out during the peer review process as well as at the conference presentation stage. Submitted papers must not be under consideration by any other journal or publication. The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly. Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor. To participate as a sponsor or exhibitor, please download and complete the Conference Sponsorship Request Form.

Application Forms

Paper Submission
Author Registration
Listener Registration
Sponsorship and Exhibition
Volunteerism

Selected Papers

Investigations of Protein Aggregation Using Sequence and Structure Based Features
M. Michael Gromiha, A. Mary Thangakani, Sandeep Kumar, D. Velmurugan
ZBTB17 Gene rs10927875 Polymorphism in Slovak Patients with Dilated Cardiomyopathy
I. Boroňová, J. Bernasovská, J. Kmec, E. Petrejčíková
Comparative Studies on Interactions of Synthetic and Natural Compounds with Hen Egg-White Lysozyme
Seifollah Bahramikia
Serum Nitric Oxide and Sialic Acid: Possible Biochemical Markers for Progression of Diabetic Nephropathy
Syed M. Shahid, Rozeena Shaikh, Syeda N. Nawab, Shah A. Qader, Abid Azhar, Tabassum Mahboob

Kongres EHA2026
2026-06-11 08:00 - 2026-06-14 17:00
W dniach 11-14 czerwca 2026 r. w Sztokholmie (Szwecja) odbędzie się Kongres EHA2026, który łączy globalną społeczność hematologów. W czasie wydarzenia zaprezentowane zostaną najnowsze aktualizacje kliniczne i badawcze w dziedzinie hematologii. Ponadto udział w Kongresie jest szansą na nawiązanie kontaktu z wiodącymi ekspertami i poznanie najnowszych osiągnięć w hematologii.
Ważne daty:

1 marca 2026 r. – termin składania streszczeń, termin składania wniosków o dotacje,
4 maja 2026 r. – termin wczesnej rejestracji,
7 maja 2026 r. – ostateczny termin składania streszczeń,
11-14 czerwca 2026 r. – Kongres EHA2026.

Szczegółowe informacje znaleźć można na stronie wydarzenia.

ESC Congress 2026
2026-08-28 08:00 - 2026-08-31 17:00
Be part of ESC Congress 2026, the world’s foremost cardiology meeting, where transformation moves from promise to practice.
This year’s Spotlight on Artificial Intelligence explores how AI is becoming a co-pilot, enhancing precision, speed, and safety in patient care. Discover AI in action, from diagnosis to delivery, through hands-on sessions, live demonstrations, and immersive learning.
Here, every subspecialty unites, creating a space to share breakthrough data, debate new ideas, and apply innovation immediately. This is where collaboration becomes progress, and transformation is not just seen but felt.
In Munich and online, ESC Congress 2026 is where practice meets policy, innovation meets responsibility, and transformation becomes collective. Because amid algorithms and automation, cardiology’s heartbeat remains human and progress begins with people. It begins with YOU.
Join us next August – Transforming cardiology, together.
Save the date! abstract submission, registration, and hotel services open mid-December.

Young Baltic Cardio 2026
2026-09-11 10:00 - 2026-09-12 16:00 | Victoria Hotel Klaipėda, S. Šimkaus g. 2, LT-92128, Klaipėda, Lithuania
The first Young Baltic Cardio Conference will bring together experts, researchers and clinicians from the Baltic countries and beyond to discuss recent advances in cardiology. The second day of the meeting will include an afternoon session dedicated to amyloidosis, with topics covering early detection of cardiac amyloidosis, TTR suppressors in clinical practice, multimodality imaging, prognostication, red flags in everyday practice and follow-up in cardiac amyloidosis.

Detailed information and the registration form are available on the event website.

Advances in the Diagnosis and Treatment of Amyloidosis in 2026
2026-09-24 07:30 - 16:00 | NYU Langone Health, 550 First Ave New York, NY United States
Advances in the Diagnosis and Treatment of Amyloidosis in 2026 is a course focused on advanced management of patients with TTR and light chain (AL) amyloidosis. Experts from multiple specialties will present recent developments in diagnosis and treatment, using real-world case scenarios to discuss the complexities of amyloidosis care.
Detailed information and the registration form are available on the event website.

2026 Amyloidosis Forum Annual Meeting
2026-09-30
The 2026 Amyloidosis Forum Annual Meeting will bring together clinicians, researchers, FDA and global health authorities, industry partners, patients and the Amyloidosis Research Consortium. Participants will present the work of stakeholder groups focused on accelerating drug development in AL and ATTR amyloidosis.

Detailed information are available on the event website.

X Interdyscyplinarna Konferencja Amyloidoza
2026-10-02 11:00 - 2026-10-03 11:00
Zapraszamy do udziału w X Interdyscyplinarnej Konferencji Amyloidoza, która odbędzie się w dniach 2-3 października 2026 r. w formule on-line.
Celem Konferencji jest aktualizacja wiedzy na temat amyloidozy oraz wymiana doświadczeń pomiędzy lekarzami różnych specjalności medycznych. Mamy nadzieję, że Konferencja przyczyni się do poprawy diagnostyki i terapii amyloidozy w Polsce, a także stanie się impulsem do wspólnych inicjatyw klinicznych i naukowych.
Szczegóły wkrótce!

2026 Global Cardio-Oncology Summit
2026-10-05 12:00 - 2026-10-07 12:00
On behalf of the International Cardio-Oncology Society, it is our honor to invite you to join us for the 2026 Global Cardio-Oncology Summit (GC-OS), to be held from October 5-7, 2026, in Williamsburg, Virginia.
GC-OS is the premier international, interdisciplinary event dedicated to advancing the prevention and management of cardiovascular disease among cancer survivors. Our theme for 2026 will be “Cardio-Oncology Innovation and Implementation for the Future,” and topics will include:

The intersection between artificial intelligence and cardio-oncology
New treatments for cardiac amyloidosis
Cardiac imaging: novel surveillance strategies and integrative & multimodality imaging
Preventive therapy and exercise interventions for cardio-toxicity
Next generation therapies in hematology and oncology
Role of the immune system in cancer and cardiovascular disease

GC-OS offers excellent opportunities for networking, collaboration, and the chance to present your own research before a global audience. In addition, historic Williamsburg, Virginia, was recently rated the “Most Underrated Travel Gem in the U.S.” Home to Colonial Williamsburg, the world’s largest living history museum, Williamsburg combines dozens of historical and cultural attractions, excellent dining and shopping, geographic beauty, and small-town charm.
As members of our expanding, and ever-evolving, scientific community, your participation in GC-OS 2026 will be instrumental to enriching our dialogues and driving new innovations. Please share this invitation with colleagues who may be interested. We look forward to welcoming you to WIlliamsburg next fall!

XX International Symposium on Amyloidosis – ISA 2026
2026-10-15 08:00 - 2026-10-18 17:00
As Chair of the Program Committee, ISA Board member Eloisa Riva is collaborating with colleagues from the Latin American Program Committee and the international Scientific Committee to develop a comprehensive program to expand knowledge and foster meaningful connections across all disciplines in the amyloidosis community. In addition to cutting-edge scientific presentations, the committees are organizing special sessions for clinicians new to amyloidosis along with discussions focused on strengthening collaboration between the Latin American and global amyloidosis communities.
During ISA 2026, you will enjoy social events that offer a true taste of Uruguay’s vibrant culture, cuisine, and hospitality. Set aside time to explore Montevideo, a city where historic architecture, coastal beauty, and a relaxed rhythm of life come together. Whether you stroll through the charming streets of Ciudad Vieja, visit the bustling Mercado del Puerto, or take in a sunset along the Rambla, Montevideo offers a uniquely memorable backdrop to your time at the conference.

ISA 2026 Symposium
2026-11-15 08:00 - 2026-11-18 17:00

68th ASH Annual Meeting and Exposition
2026-12-12 08:00 - 2026-12-15 17:00
Save the date for the 68th ASH Annual Meeting and Exposition, taking place December 12–15, 2026, in New Orleans, Louisiana, and online!
